abstract |
The present invention is directed to treating a COX-2 mediated disease comprising administering a novel compound of Formula I and a nontoxic therapeutically effective amount of the compound of Formula I to a patient in need thereof. It includes a method. The present invention also encompasses pharmaceutical compositions for treating COX-2 mediated diseases comprising a compound of Formula (I).n n n Formula I |